Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease-Reference-Cited by-同舟云学术

Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease

Published:1992-03 Issue:5 Volume:88 Page:513-523
ISSN:0340-6717
Container-title:Human Genetics
language:en
Short-container-title:Hum Genet

Author:

Leinekugel P.,Michel S.,Conzelmann E.,Sandhoff K.

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1007/BF00219337.pdf

Reference42 articles.

1. Banerjee A, Burg J, Conzelmann E, Carroll M, Sandhoff K (1984) Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization. Hoppe-Seyler's Z Physiol Chem 365:347–356

2. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917

3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

4. Conzelmann E, Sandhoff K (1979) Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. Hoppe-Seyler's Z Physiol Chem 360:1837–1849

5. Conzelmann E, Sandhoff K (1983/84) Partial enzyme deficiencies: residual activities and the development of neurologic disorders. Dev Neurosci 6:58–71

Cited by 312 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LysoGb3 quantification facilitates phenotypic categorization of Fabry disease patients: Insights gained by a novel MS/MS method;Clinica Chimica Acta;2024-07

2. Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials;Neurotherapeutics;2024-07

3. Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders;International Journal of Molecular Sciences;2024-01-15

4. Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis;Frontiers in Molecular Neuroscience;2023-11-30

5. Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric β-Galactosidase correctors;PLOS ONE;2023-11-29